Evolv Technologies Holdings Securities Settlement
This settlement is closed to new claims — the deadline was August 12, 2026. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Investors purchased publicly traded common stock of Evolv Technologies Holdings Inc. during a specific period and are entitled to compensation from a securities class action settlement. The page does not explicitly state what wrongdoing Evolv allegedly committed.
Do you qualify?
Anyone who purchased or otherwise acquired Evolv Technologies Holdings Inc. publicly traded common stock between June 28, 2021 and October 25, 2024, inclusive, or who purchased Evolv common stock pursuant to or traceable to the Company's Registration Statement.
How to file
Submit a Proof of Claim and Release form online or download a blank Claim Form from the Important Documents page by August 12, 2026. The form can be completed online to be eligible for a payment.
Common questions
- What is the claim deadline for the Evolv Technologies Holdings Securities Settlement?
- This settlement is closed to new claims — the deadline was August 12, 2026. Once a claim deadline passes you generally forfeit your share, even if you qualified.
- Do I need proof of purchase for the Evolv Technologies Holdings Securities Settlement?
- Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
- Is the Evolv Technologies Holdings Securities Settlement notice real, or a scam?
- Claims are filed at evolvtechsecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the Evolv Technologies Holdings Securities Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for September 24, 2026; no payments can be issued before a settlement receives final approval.
Who's involved
Plaintiffs
- Chris Swanson
- Tim R. Carillo
- Chris Williams
- Robert Falk
Defendants
- Neil Glat
- Charles Goldman
- Sezaneh Taherian
- Thomas J. Sullivan
- Charlie Baynes-Reid
- Brian Mathis
- Kathleen Harris
- Marc Saiontz
+ 6 more
Counsel for plaintiffs
- Joseph D CohenGlancy Prongay Wolke & Rotter LLP
- Casey SadlerGlancy Prongay Wolke & Rotter LLP
- Daryl DeValerio AndrewsAndrews DeValerio
Counsel for defendants
- Brendan BlakeGoodwin Procter LLP
- Jocelyn GreerMorrison & Foerster LLP
- Nathaniel Mendell
- Jamie A. LevittMorrison & Foerster LLP
- R. Todd CronanGoodwin Procter, LLP
- Nathan Andrew Field SandalsLatham & Watkins LLP
- Justin WardGoodwin Procter LLP
- Jennifer B. LuzGoodwin Procter, LLP
- Jeff G. HammelLatham & Watkins LLP
Parties and counsel from the public court docket. Listing an attorney here isn't an endorsement, and ClaimWatch isn't affiliated with any of them.
In the news
- Evolv Technologies Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 24, 2024 to Discuss Your Rights - EVLVMarketscreener.com · May 23, 2024
- EVLV Investors Have Opportunity to Lead Evolv Technologies Holdings, Inc. Securities Fraud LawsuitMarketscreener.com · April 26, 2024
Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Revance Securities Settlement
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
Not yet determinable; depends on number of valid claims submitted
Biogen Securities Litigation Settlement
Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.
NJ Bureau of Securities Settlement with Credit Suisse
Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.